A scientific committee chaired has taken care to put together a program that covers the most relevant issues in the field today.
Helicobacter species induce different immune responses depending on the gut environment
28 Aug 2017by Andreu Prados
A new study has found that Helicobacter species that routinely interact with the host immune system may elicit either homeostatic or inflammatory immune responses depending on the gut environment.
Report covers take-home points from the 2017 Gut Microbiota for Health World Summit in Paris
19 Jul 2017by GMFH Editing Team
The GMFH editing team is pleased to bring you the Gut Summit 2017 official report.
A recent randomised placebo-controlled trial, led by Prof. Thomas Borody from the Centre for Digestive Diseases in Sydney (Australia), has found that faecal microbiota transplantation induces clinical remission and endoscopic improvement in patients with active ulcerative colitis.
A new study has identified a gut microbial signature for Crohn’s disease that could avoid invasive diagnostic testing
13 Mar 2017by Andreu Prados
A recent study, led by Dr. Chaysavanh Manichanh from the Group of Physiology and Digestive Physiopathology of the Vall d’Hebron Research Institute in Barcelona (Spain), has identified for the first time a group of 8 bacterial taxa that could discriminate CD and non-CD independently of geographical region.
A fiber-deprived diet may degrade the colonic mucus barrier and promote enteric pathogen infection in mice
28 Dec 2016by Andreu Prados
A recent study, led by Dr. Eric Martens from the University of Michigan Medical School in Ann Arbor (USA), has found that a fiber-deprived diet may lead to a degradation of the colonic mucus layer and enhance enteric pathogen infection in mice.
Fecal microbiota transplantation (FMT) for patients with ulcerative colitis (UC) has shown mixed clinical results (see recent trials here and here). In a new pilot study, published as open access, Faming Zhang and colleagues tested the safety and efficacy of a "step-up" FMT strategy in 15 steroid-dependent UC patients.
Difference in gut fungi populations found in children with inflammatory bowel disease
27 Jul 2015by GMFH Editing Team
Digestive disorders, from gut discomfort to inflammatory bowel diseases (IBD) and cancer, are rising in many countries. Research and clinical studies on the interaction of gut microbiota and digestive health, are providing stimulating data. However, their connection is not fully understood and gut fungi have recently been suggested to play a role as well.
FMT for ulcerative colitis holds promise despite discontinued Canadian trial, says Moayyedi
20 Jul 2015by Kristina Campbell
Dr. Paul Moayyedi, a gastroenterologist and researcher at McMaster University in Hamilton, Canada, was the first author of a study published earlier this year that investigated fecal microbiota transplantation (FMT) as a way to induce remission in patients with ulcerative colitis (UC). (See the study summary here.)
Ecobiotherapy: Using microbial ecosystems for a therapeutic purpose
25 Jun 2015by Kristina Campbell
In a recent paper, researchers from Canada have coined the term 'ecobiotherapy' to refer to "the use of microbial ecosystems for a therapeutic purpose.
